David Protein Says ‘Diet’ Trends Are Over, GLP-1s Upend Markets
David Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
Budgeting aids success by clarifying priorities, reducing waste, and creating a roadmap toward your desired financial outcomes.
19,451 articlesDavid Rahal, founder and CEO of David Protein, argues GLP-1 drugs have upended the diet-trend cycle, reshaping how br...
As markets stabilize in 2026, a growing argument centers on placing the Vanguard Mid-Cap ETF (VO) inside a Roth IRA t...
Oil prices rise as President Trump signals a toll on Strait of Hormuz shipping, amplifying supply concerns and forcin...
Leveraged ETFs promise outsized gains, but their daily reset can distort long-term results. This guide breaks down ho...
A single headline can move stock in moments, but the real story is rarely a simple one. This article dives into why a...
After years watching Plug Power, I’m starting to see potential catalysts. This article lays out why the bear case rem...
A well-known AI stock has retraced roughly a quarter from its high, creating a potential entry point for investors. T...
Oracle has fallen this year as investors weigh legacy strengths against AI disruption. This guide breaks down the AI ...
Amazon's latest move highlights a broader theme: AI investment can lift near-term costs even as revenue opportunities...
As earnings season unfolds, SPIR investors want clarity on the drivers behind spire (spir) 2026 earnings. This guide ...
As markets enter the quieter summer season, space-themed investing offers a targeted way to capture innovation. This ...
Gold resumes its ascent in 2026, with three ETFs offering distinct risk paths to access the metal. GLD, GLDM, and GDX...